ReviewPolymers2024
A Valuable Source of Promising Extremophiles in Microbial Plastic Degradation.
Review in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Characterization and GC-MS-Based Identification of Possible PVC Degradation Pathways of Bacteria for Sustainable Microplastic Bioremediation.Microorganisms · 2026Article
- Improving Yield and Thermostability of PETase as a Maltose Binding Protein Fusion in the Periplasm ofInternational journal of molecular sciences · 2026Article
- Engineered microbes to enable a circular economy for biodegradable plastics.Frontiers in microbiology · 2026Review
- Life cycle design of polyhydroxyalkanoates (PHA).National science review · 2025Review
- Microplastic Pollution: A Global Environmental Crisis Impacting Marine Life, Human Health, and Potential Innovative Sustainable Solutions.International journal of environmental research and public health · 2025Review
- Biodegradation of polyhydroxyalkanoates: current state and future prospects.Frontiers in microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Plastics have accumulated in open environments, such as oceans, rivers, and land, for centuries, but their effect has been of concern for only decades. Plastic pollution is a global challenge at the forefront of public awareness worldwide due to its negative effects on ecological systems, animals, human health, and national economies. Therefore, interest has increased regarding specific circular economies for the development of plastic production and the investigation of green technologies for plastic degradation after use on an appropriate timescale. Moreover, biodegradable plastics have been found to contain potential new hazards compared with conventional plastics due to the physicochemical properties of the polymers involved. Recently, plastic biodegradation was defined as microbial conversion using functional microorganisms and their enzymatic systems. This is a promising strategy for depolymerizing organic components into carbon dioxide, methane, water, new biomass, and other higher value bioproducts under both oxic and anoxic conditions. This study reviews microplastic pollution, the negative consequences of plastic use, and the current technologies used for plastic degradation and biodegradation mediated by microorganisms with their drawbacks; in particular, the important and questionable role of extremophilic multi-enzyme-producing bacteria in synergistic systems of plastic decomposition is discussed. This study emphasizes the key points for enhancing the plastic degradation process using extremophiles, such as cell hydrophobicity, amyloid protein, and other relevant factors. Bioprospecting for novel mechanisms with unknown information about the bioproducts produced during the plastic degradation process is also mentioned in this review with the significant goals of CO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.